OncoCyte Investor Relations Material
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. Its tests apply genetic analysis technology to advance early detection of cancer. The company's lead product candidates are Circulating Tumor Cell (CTC), a blood test to detect lung cancer; and DetermaIO, a bioinformatic analysis software that provides interpretative information on the outputs from various types of assays, including CTC. It is also developing DetermaVu, a cell free DNA blood test for detecting various types of lung cancer; DetermaSolver, a proprietary technology.
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
The Story of Jensen Huang and Nvidia
When looking at NVIDIA’s Jensen Huang today, it is easy to stereotype him as your archetypical big tech CEO. He doesn’t wear suits like a Wall Street Chairman, instead opting to wear his now-iconic leather jackets and casual polo shirts.
6 Dec 2023
Neglect of Probability: A Hidden Risk in Decision Making
The concept of "probability" should take center stage in our decision-making processes.
4 Dec 2023
🇺🇸 United States